| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/15/1999 | EP0941064A1 PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED RELEASE OF beta -LACTAM ANTIBIOTICS |
| 09/15/1999 | EP0941063A1 Transdermal compositions containing levosimendan |
| 09/15/1999 | EP0941054A1 Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
| 09/15/1999 | EP0941039A1 Transdermal administration of ment |
| 09/15/1999 | EP0850065B1 Transdermal therapeutical system for silatran compounds |
| 09/15/1999 | EP0804239B1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof |
| 09/15/1999 | EP0799188B1 Amides of mono and dicarboxylic acids with glycosamines, selectively active on the cannabinoid peripheral receptor |
| 09/15/1999 | EP0759899B1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
| 09/15/1999 | EP0758314B1 Compounds containing a michael-acceptor, especially maleimide or maleic acid derivatives, directly or indirectly linked to a chromophore and their use in long lasting sunscreen compositions |
| 09/15/1999 | EP0749421B1 Sulphonamide derivatives as aspartyl protease inhibitors |
| 09/15/1999 | EP0748383B1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
| 09/15/1999 | EP0741697B1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 09/15/1999 | EP0733051B1 Bicyclic heterocycles as neurokinin a antagonists |
| 09/15/1999 | EP0679194B1 Method to predict active growth of bacteria adhered to a surface |
| 09/15/1999 | EP0656001B1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 09/15/1999 | EP0652767B1 Treatment of human lactation failure |
| 09/15/1999 | EP0652752B1 Water-dispersible tablets |
| 09/15/1999 | EP0644883B1 Enniatines and enniatine derivates used to control endoparasites |
| 09/15/1999 | EP0641339B1 Azaspiro quinolone antibacterial agents |
| 09/15/1999 | EP0637242B1 Agents for treating substance abuse disorders |
| 09/15/1999 | EP0611304B1 Use of acetylated mannan (acemannan) for the regulation of blood cholesterol levels and for removing plaques in blood vessels |
| 09/15/1999 | EP0593463B1 Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
| 09/15/1999 | EP0567470B1 Pseudomonas peptide composition and method for producing the same |
| 09/15/1999 | CN1228786A Hot-water extract of nemacystis decipiens and use theirof |
| 09/15/1999 | CN1228785A Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same |
| 09/15/1999 | CN1228780A Phosphinic acid amides as matrix metalloprotease inhibitors |
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228778A Pyridazino [4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists |
| 09/15/1999 | CN1228777A Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 09/15/1999 | CN1228776A Cis-substituted aminocyclopropane derivatives |
| 09/15/1999 | CN1228775A Benzofurans and benzopyrans as chronobiological agents |
| 09/15/1999 | CN1228773A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228772A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228771A 1,3-diheterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228770A Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 09/15/1999 | CN1228768A Insect-repellent formulation |
| 09/15/1999 | CN1228767A Bidentate metalloprotease inhibitors |
| 09/15/1999 | CN1228765A New amidino derivatives and their use as thrombin inhibitors |
| 09/15/1999 | CN1228764A Inhibitors of oleamide hydrolase |
| 09/15/1999 | CN1228758A Haphthyl compounds, intermediates, compositions and methods of use |
| 09/15/1999 | CN1228712A Aqueous-based pharmaceutical composition |
| 09/15/1999 | CN1228710A Pharmaceutical composition containing lornoxicam and disodic salt of EDTA |
| 09/15/1999 | CN1228709A Multivalent DTP-POLID vaccines |
| 09/15/1999 | CN1228706A Hydrogenous medicament |
| 09/15/1999 | CN1228705A Use of oligosaccharide as immunomodulator in dermato-cosmetic composition |
| 09/15/1999 | CN1228704A Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles |
| 09/15/1999 | CN1228703A Chelating agents and their metal chelates for treating free radicals induced conditions |
| 09/15/1999 | CN1228702A Transdermal therapeutical approach involving combination of active substances containing oestriol |
| 09/15/1999 | CN1228701A Heterocyclic compounds with thrombolytic activity and their use for treating thrombosis |
| 09/15/1999 | CN1228700A Tablet with controlled release of alfuzosine chlorydrate |
| 09/15/1999 | CN1228699A Antifungal composition with enhanced bioavailability |
| 09/15/1999 | CN1228698A Antithrombotic and antiatherogenic pharmaceutical composition including thienopyridine derivative and HMG-CoA-reductase inhibitor |
| 09/15/1999 | CN1228697A Method for in vivo reduction of iron levels and compositions useful therefor |
| 09/15/1999 | CN1228696A Use of PKC inhibitors for manufacture of medicament for treatment of AIDS |
| 09/15/1999 | CN1228695A Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta [b] benzofurans |
| 09/15/1999 | CN1228694A Method of reducing cardiotoxicity of antitumor agent using manganese compound |
| 09/15/1999 | CN1228693A Oral composition comprising triazole antifungal compound |
| 09/15/1999 | CN1228678A Improved method for systemic administration of 2,4-dienoic acid-type insecticides to terrestrial mammals |
| 09/15/1999 | CN1228432A Method for extracting material containing raw anthocyanidin from ginkgo leaf by supercritical carbon dioxide |
| 09/15/1999 | CN1228431A Derivative of 2-aryl imidazo [2,1-a] isoquinoline and its use |
| 09/15/1999 | CN1228430A 1-isothiazolidinone derivatives of azetidine-2-one, processes for preparation thereof and use thereof |
| 09/15/1999 | CN1228427A Method for extracting and separating natural vitamin E from soybeam deodorized material by supercritical CO2 |
| 09/15/1999 | CN1228422A Process for preparing naphthyridones and intermediates |
| 09/15/1999 | CN1228414A New benzocyclobutane compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/15/1999 | CN1228409A Preparation of L-threonic acid and threonete |
| 09/15/1999 | CN1228321A Drug for curing stone of urinary system |
| 09/15/1999 | CN1228306A Eye drops for curing electric ophthalimia |
| 09/15/1999 | CN1228305A Food capable of improving liver function |
| 09/15/1999 | CN1228303A Drug composition for curing gynaecological vaginitis |
| 09/15/1999 | CN1228302A Preparation of ampicillin skin test liquid and its usage |
| 09/15/1999 | CN1228254A Alcohol based anti-microbial compositions with cosmetic apparatus |
| 09/15/1999 | CN1045089C 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1, 3-propanediol derivative |
| 09/15/1999 | CN1045088C Purine and guanine compounds as inhibitors of PNP |
| 09/15/1999 | CN1045087C Preparation of imidazopyridine derivative |
| 09/15/1999 | CN1045084C Novel compound with platelet aggregation inhibitor activity and its use, and drug composition containing the same |
| 09/15/1999 | CN1045083C Lifibrol antilipemic agent and its use |
| 09/14/1999 | US5952513 Benzo b! thiophene compounds |
| 09/14/1999 | US5952511 Indolin-2-one derivatives |
| 09/14/1999 | US5952510 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives having PDE IV and cytokine inhibiting activity |
| 09/14/1999 | US5952504 Reacting a sulfonated, halogenated or phosphonated 1,7-naphthyridine compounds with an aromatic amine derivative; antiulcer agent |
| 09/14/1999 | US5952502 Administering to the mammal a dioxolane compound for fungal treatment |
| 09/14/1999 | US5952500 Nucleoside derivatives |
| 09/14/1999 | US5952499 Therapeutic compound-fatty acid conjugates |
| 09/14/1999 | US5952495 Preparation of 14-hydroxynormorphinones from normorphinones |
| 09/14/1999 | US5952490 Oligonucleotides having a conserved G4 core sequence |
| 09/14/1999 | US5952478 Nucleotides and analogs in which both the 3' oxy linkage and the 5' oxy linkage are replaced by carbon linkages; for antisense agents; viricides against influenza, herpes and human immune deficiency virus; anticarcinogenic agents |
| 09/14/1999 | US5952393 Anticholestereol agent consists of phytosterol and policosanol |
| 09/14/1999 | US5952392 Therapeutic treatment of viral infections and skin inflammation using a mixture containing a nonionic surfactant block polymer |
| 09/14/1999 | US5952390 Antiinflammatory agents; treatment for psoriasis |
| 09/14/1999 | US5952389 Methods of treating tardive dyskinesia and other movement disorders |
| 09/14/1999 | US5952388 Administering effective dosage |
| 09/14/1999 | US5952387 Photostable aqueous solution containing benzyl alcohol derivatives |
| 09/14/1999 | US5952385 Enzyme inhibitor for treating endotoxic shock, hypotension such as septic (toxic) shock and therapy with certain cytokines |
| 09/14/1999 | US5952384 Contacting the mammalian cell with an inflammatory mediator selected from the group consists of pyruvate and pyruvate precursor capable of reducing undesired inflammatory response and is antioxidant |
| 09/14/1999 | US5952383 Liquid support oil, suspending agent, homogenizing agent, surfactant and expedients; antiinflammatory agents |
| 09/14/1999 | US5952382 Inhibiting the biological effects of an overregulation of retinoid acid receptors and/or of a hypervitaminosis a; treating skin disorder, eye vision defects, skin aging |
| 09/14/1999 | US5952381 Para-substituted phenylene derivatives |
| 09/14/1999 | US5952380 Method for treating diarrhea |
| 09/14/1999 | US5952378 Methods and means for drug administration |
| 09/14/1999 | US5952375 Compounds and methods for synthesis and therapy |